InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by C. Lohmann. Director active across 1 company, notably Vivoryon Therapeutics N.V.. In total, 3 filings have been published. History available since 22 June 2022. The latest transaction was disclosed on 30 June 2025 (Purchase). Regulator: AFM. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations